Immunovant (IMVT) Q1 2026 Earnings

6FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.73
-0.69
-0.65
-0.61

Details

Expected EPS
-0.713433
Actual EPS
-0.61
Surprise EPS
0.1
Surprise Percent
+14.5%

Description

Immunovant (IMVT) has reported earnings of -0.61 per share for Q1 2026.

0 Comments

Share your thoughts